Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
The Surgical Clinics of North America|July 15, 2018
Management of the Axilla in the Patient with Breast CancerKo Un Park, Abigail CaudleAnnals of Surgical Oncology|May 1, 2019
Neoadjuvant Chemotherapy does not Increase Complications in Oncoplastic Breast-Conserving SurgeryKarri Adamson, Mariana Chavez-MacGregor, Abigail Caudle, et al.Annals of Surgical Oncology|October 12, 2022
Leveraging the Multidisciplinary Tumor Board for Dissemination of Evidence-Based Recommendations on the Staging and Treatment of Gastric Cancer: A Pilot StudyShivani N Mehta, Edna C Shenvi, Sarah L Blair, et al.Plos One|March 4, 2014
Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) databaseJun Wang, Elizabeth A Mittendorf, Aysegul A Sahin, et al.Journal of Surgical Oncology|February 12, 2021
Acceptability of 3D-printed breast models and their impact on the decisional conflict of breast cancer patients: A feasibility studyLumarie Santiago, Robert J Volk, Cristina M Checka, et al.International Journal of Radiation Oncology, Biology, Physics|April 2, 2016
Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy ReformShervin M Shirvani, Jing Jiang, Anna Likhacheva, et al.International Journal of Radiation Oncology, Biology, Physics|September 26, 2023
Racial and Ethnic Differences in Long-Term Adverse Radiation Therapy Effects Among Breast Cancer SurvivorsKevin Diao, Xiudong Lei, Weiguo He, et al.Annals of Surgery|May 26, 2023
Patient-reported Quality of Life After Breast-conserving Surgery With Radiotherapy Versus Mastectomy and ReconstructionKevin Diao, Xiudong Lei, Weiguo He, et al.Annals of Surgical Oncology|December 27, 2025
Axillary Management after Neoadjuvant Endocrine Therapy (NET)Laura Leonard, Min Yi, Emma Wingate, et al.Annals of Surgical Oncology|October 23, 2024
Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant ChemotherapyAlycia So, Min Yi, Janine M Simons, et al.Pageof 2